Careers
Madhumathi Palaniappan's Profile
B.Pharm
Madhu, an alumni of Madras Medical College writes on drugs and handles the drug section on Medindia. Her long term dream and desire is to become an entrepreneur in the Pharma field.
Written / Edited / Medically Reviewed
Histone Deacetylase Inhibitors: Cancer Therapy Offers Hope in Psoriasis Treatment
Psoriasis is an autoimmune disease characterized by patches of abnormal skin. Histone deacetylase inhibitors for cancer promise treatment for psoriasis.
Anti-tumor Drug Variations Prove Effective for Cancer Treatment
Variations of anti-tumor agents like epothilones could be effective even for drug-resistant cancer treatment.
Key to Better, Shorter Tuberculosis Treatment Identified
A new study found that blocking the Tuberculosis germs by metabolic escape pathways may be a key to better, shorter treatment.
Can Beta-Blockers Benefit Heart Attack Patients?
Heart attack occurs when there is damage to the heart muscle. Beta-blockers may not show possible benefits in heart attack patients, reveals study.
FDA Approves First Drug Targeting Specific DNA Changes In Solid Cancers
First ever drug therapy for solid cancer in any location, targeting specific DNA changes has been granted approval by the U.S. Food and Drug Administration (FDA).
